Updated Efficacy Results for Avelumab in Metastatic Urothelial Carcinoma

July 11, 2017
Andrea B. Apolo, MD

Andrea B. Apolo, MD, discusses a pooled analysis of 2 cohorts of the phase 1b JAVELIN trial, which is exploring avelumab (Bavencio) for the treatment of patients with metastatic urothelial carcinoma.